Sofinnova Partners portfolio

Sofinnova Partners (Venture capital) is known to hold 128 companies, 60 of them startups. 21 of them are hiring now, with 1,341 open roles. In the last 12 months rounds in the press named it 1 times (1 as the lead). Its companies closed 17 venture rounds in 12 months, raising $678.9M. Most of them work in Drug Discovery, Cell & Gene Therapy, Immunology & Inflammation Therapeutics.

Source: Alion Venture capital Oct 20, 2026
Investments
128
60 of them startups
Hiring now
21
1,341 open roles
Deals in 12 months
1
1 as the lead
Rounds in 12 months
17
$678.9M raised
Exits
18

Companies Sofinnova Partners has invested in

Chroma Bio, Inc. United States Venture round $135M · 3 yr ago portfolio pageSep 25
Verona Pharma Venture round $200.2M · 6 yr ago portfolio pageOct 2
MaxCyte Cell & Gene Therapy · United States Venture round $760k · 10 yr ago 4 roles portfolio pageSep 25
Medtronic Cardiovascular Devices · Ireland 1244 roles portfolio pageSep 25
Ascendis Pharma Prescription Drugs · Denmark 26 roles portfolio pageSep 25
DBV Technologies Immunology & Inflammation Therapeutics 6 roles portfolio pageSep 25
Avantium Chemical Manufacturing · Netherlands 3 roles portfolio pageSep 25
90Phutzac Sports Media portfolio pageSep 25
Calliditas Therapeutics AB Biologics & Biosimilars portfolio pageSep 25
DISCO Pharmaceuticals GmbH Oncology Therapeutics · Germany portfolio pageSep 25
Inventiva Cardiometabolic Therapeutics portfolio pageSep 25
Meiogenix Synthetic Biology portfolio pageSep 25
Muna Therapeutics Neurology & CNS Therapeutics portfolio pageSep 25

Focus

Markets
Drug Discovery6%
Cell & Gene Therapy4%
Immunology & Inflammation Therapeutics4%
Synthetic Biology4%
Rare Disease Therapeutics3%
Biologics & Biosimilars3%
Food Biotechnology3%
Surgical Instruments & Devices3%
Where its companies are
France11%
United States9%
United Kingdom3%
Italy2%
Denmark2%
Germany2%
Switzerland2%
Netherlands1%
Stage of its companies
Venture, series not stated60%
Series B14%
Pre-seed & seed10%
Series C and later10%
Series A7%

Questions about Sofinnova Partners

How many companies has Sofinnova Partners invested in?

Sofinnova Partners is known to hold 128 companies: 60 startups, and 18 exits so far, read from its own portfolio page and the funding rounds that name it.

Is Sofinnova Partners investing now?

Yes: in the last 12 months 1 rounds in the press named Sofinnova Partners (1 as the lead), and 0 companies joined its portfolio page in 90 days.

What does Sofinnova Partners invest in?

The markets of the companies Sofinnova Partners holds: Drug Discovery (6%), Cell & Gene Therapy (4%), Immunology & Inflammation Therapeutics (4%), Synthetic Biology (4%), Rare Disease Therapeutics (3%).

Which Sofinnova Partners portfolio companies are hiring?

21 companies Sofinnova Partners holds are hiring now, with 1,341 open roles listed on this page.

Who does Sofinnova Partners invest alongside?

The investors that hold the most companies together with Sofinnova Partners: M Ventures, Kurma Partners, Sofinnova Investments, NEA, Aisling Capital.

How this page is made

A company counts as a holding when the investor’s own portfolio page links to it, a program’s catalog lists it, or a funding round in the press names the investor. The numbers are rebuilt every night; each company shows where it came from and when it was first seen.

Sources: its portfolio page, read Oct 18; 10 rounds in the press that name it

Sofinnova Partners portfolio: 128 known companies. Alion, Oct 20, 2026. https://alion.io/company/sofinnova-partners/portfolio

Licence: CC BY-SA 4.0JSON